You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Obeticholic acid

Showing 1 - 25 of 7,922
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Leuven (Ocaliva, Placebo)

Recruiting
  • Healthy
  • Leuven, Vlaams-Brabant, Belgium
    KU Leuven
Feb 13, 2023

Barrett Esophagus Trial (Obeticholic Acid, Placebo Administration)

Not yet recruiting
  • Barrett Esophagus
  • Obeticholic Acid
  • Placebo Administration
  • (no location specified)
Oct 13, 2022

Pruritus Trial in Baltimore (Obeticholic acid, Linerixibat)

Completed
  • Pruritus
  • Baltimore, Maryland
    GSK Investigational Site
Nov 4, 2022

Evaluate Effectiveness of OCA on Hepatic Outcomes in PBC

Enrolling by invitation
  • Primary Biliary Cholangitis
  • Obeticholic Acid 5 MG
  • +2 more
  • San Diego, California
    Intercept Pharmaceuticals, Inc
Dec 15, 2022

Biliary Atresia Trial (OCA, Matching Placebo)

Not yet recruiting
  • Biliary Atresia
  • OCA
  • Matching Placebo
  • (no location specified)
Nov 2, 2023

Non-alcoholic Steatohepatitis Trial in Tanta (Obeticholic Acid Oral Tablet, Vit E)

Active, not recruiting
  • Non-alcoholic Steatohepatitis
  • Obeticholic Acid Oral Tablet
  • Vit E
  • Tanta, Egypt
    Department of Tropical Medicine and Infectious Diseases, Faculty
Oct 6, 2022

Primary Biliary Cholangitis Trial in Beijing (Obeticholic Acid Tablets(OCA), UDCA, Placebo)

Recruiting
  • Primary Biliary Cholangitis
  • Obeticholic Acid Tablets（OCA）
  • +2 more
  • Beijing, China
    Beijing Friendship Hospital
Jul 7, 2022

Attenuated Familial Adenomatous Polyposis, Colorectal Carcinoma, Duodenal Carcinoma Trial in Puerto Rico, United States

Recruiting
  • Attenuated Familial Adenomatous Polyposis
  • +3 more
  • Biopsy
  • +2 more
  • Scottsdale, Arizona
  • +5 more
Dec 30, 2022

Evaluate Effectiveness of OCA on Hepatic Outcomes in PBC

Completed
  • Primary Biliary Cholangitis
  • Obeticholic Acid 5 MG
  • +2 more
  • San Diego, California
    Intercept Pharmaceuticals, Inc
Jul 30, 2022

Non-Alcoholic Fatty Liver Disease Trial in Dhaka (Obeticholic acid)

Completed
  • Non-Alcoholic Fatty Liver Disease
  • Obeticholic acid
  • Dhaka, Bangladesh
    Department of Hepatology
May 15, 2022

Familial Partial Lipodystrophy Trial in Dallas (Obeticholic Acid, Placebo)

Active, not recruiting
  • Familial Partial Lipodystrophy
  • Obeticholic Acid
  • Placebo
  • Dallas, Texas
  • +1 more
Jan 23, 2022

Attenuated Familial Adenomatous Polyposis, Colorectal Carcinoma, Duodenal Carcinoma Trial in Puerto Rico, United States

Not yet recruiting
  • Familial Adenomatous Polyposis
  • Obeticholic Acid
  • Placebo
  • Phoenix, Arizona
  • +4 more
Nov 18, 2021

Biliary Atresia Trial in Worldwide (OCA 0.1mg, OCA 1.5mg, OCA 5mg)

Active, not recruiting
  • Biliary Atresia
  • OCA 0.1mg
  • +2 more
  • Brussel, Belgium
  • +16 more
May 6, 2022

Primary Biliary Cholangitis Trial in United States (Bezafibrate 100 MG, Bezafibrate 200 MG, Obeticholic Acid 5 MG)

Recruiting
  • Primary Biliary Cholangitis
  • Bezafibrate 100 MG
  • +4 more
  • Dothan, Alabama
  • +25 more
Aug 24, 2022

Primary Biliary Cirrhosis Trial in Changchun (Obeticholic Acid Tablets, UDCA, Placebo)

Recruiting
  • Primary Biliary Cirrhosis
  • Obeticholic Acid Tablets
  • +2 more
  • Changchun, Jilin, China
    The first hospital of Jilin University
Jul 23, 2021

Obesity Trial in Göteborg (Obeticholic acid, Obeticholic acid )

Unknown status
  • Obesity
  • Obeticholic acid
  • Obeticholic acid placebo
  • Göteborg, Sweden
  • +1 more
Aug 22, 2020

Primary Biliary Cholangitis Trial in Worldwide (Obeticholic acid, Bezafibrate 200 MG, OCA Placebo)

Recruiting
  • Primary Biliary Cholangitis
  • Obeticholic acid
  • +5 more
  • Bedford Park, Perth, Australia
  • +67 more
Dec 2, 2022

Cholestasis Trial in Cambridge (GSK2330672 (linerixibat), Obeticholic acid)

Completed
Has Results
  • Cholestasis
  • GSK2330672 (linerixibat)
  • Obeticholic acid
  • Cambridge, United Kingdom
    GSK Investigational Site
Jul 1, 2020

Primary Sclerosing Cholangitis (PSC) Trial in Italy, United States (Obeticholic Acid (OCA), Placebo)

Completed
Has Results
  • Primary Sclerosing Cholangitis (PSC)
  • Obeticholic Acid (OCA)
  • Placebo
  • Phoenix, Arizona
  • +35 more
Jun 11, 2021

Primary Biliary Cirrhosis Trial in Worldwide (Obeticholic Acid (OCA), Placebo)

Completed
Has Results
  • Primary Biliary Cirrhosis
  • Obeticholic Acid (OCA)
  • Placebo
  • Sacramento, California
  • +58 more
Apr 9, 2021

Primary Bile Acid Malabsorption, Secondary Bile Acid Malabsorption, Chronic Diarrhoea Trial in London (Obeticholic acid)

Completed
Has Results
  • Primary Bile Acid Malabsorption
  • +2 more
  • Obeticholic acid
  • London, United Kingdom
  • +1 more
Mar 6, 2020

Liver Cirrhosis, Biliary Trial in Worldwide (Placebo, Obeticholic Acid (OCA))

Completed
Has Results
  • Liver Cirrhosis, Biliary
  • Placebo
  • Obeticholic Acid (OCA)
  • Detroit, Michigan
  • +20 more
May 28, 2021

Alcoholic Hepatitis Trial in United States (Placebo, 10 mg Obeticholic Acid (OCA))

Terminated
Has Results
  • Alcoholic Hepatitis
  • Placebo
  • 10 mg Obeticholic Acid (OCA)
  • Indianapolis, Indiana
  • +3 more
Jan 16, 2020

Liver Cirrhosis, Biliary Trial in Worldwide (Obeticholic Acid (OCA), Placebo)

Terminated
  • Liver Cirrhosis, Biliary
  • Obeticholic Acid (OCA)
  • Placebo
  • Rialto, California
  • +39 more
Jul 30, 2021

Non Alcoholic Steatohepatitis (NASH) Trial in Worldwide (Obeticholic Acid, Placebo)

Active, not recruiting
  • Non Alcoholic Steatohepatitis (NASH)
  • Obeticholic Acid
  • Placebo
  • Birmingham, Alabama
  • +345 more
Jan 24, 2023